The inside story of a disgraced drugmaker
FT News Briefing
00:00
Pharmaceutical Ambiguities: The Insys Controversy
This chapter explores the unethical sales strategies and moral dilemmas within a pharmaceutical company led by controversial figures. It reveals how aggressive marketing tactics and a profit-first mentality contributed to the opioid addiction crisis, while also highlighting the role of short sellers in uncovering the company's dubious practices.
Transcript
Play full episode
